SCHEMBL2328841

SCHEMBL2328841

NC(=O)C(=O)NCCCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.64
▸ NPC1 O15118 3/20 0.62
▸ HPGD P15428 3/20 0.62
▸ RAB9A P51151 2/20 0.62
▸ GAA P10253 1/20 0.62
▸ EPHX2 P34913 1/20 0.60
▸ PLAAT3 P53816 2/20 0.58
▸ PLAAT5 Q96KN8 2/20 0.58
▸ PLAAT2 Q9NWW9 2/20 0.58
▸ PLAAT4 Q9UL19 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ EPHX1 P07099 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ CNR1 P21554 1/20 0.57
▸ TAAR1 Q96RJ0 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298030 0.89 PLAAT5 (0.66) NPC1RAB9APLAAT3PLAAT5PLAAT2
SCHEMBL13860790 0.85 L3MBTL1 (0.68) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL1953254 0.85 L3MBTL1 (0.68) L3MBTL1NPC1HPGDRAB9AGAA
Hydrochloric Acid SCHEMBL27759637 0.84 L3MBTL1 (0.66) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL164622 0.81 L3MBTL1 (0.72) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL15093821 0.81 EPHX2 (0.86) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL15224134 0.81 L3MBTL1 (0.72) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL1955322 0.80 TRPV1 (0.65) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL5932867 0.79 L3MBTL1 (0.70) L3MBTL1NPC1HPGDRAB9AGAA
SCHEMBL10949637 0.79 L3MBTL1 (0.60) L3MBTL1NPC1HPGDRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117645579-A Aza-fused ring compounds as RIPK1 inhibitors and uses thereof 科辉智药生物科技(深圳)有限公司 2024-03-05 — — CN disclosed
WO-2020149129-A1 METHOD FOR PRODUCING ASYMMETRIC COMPOUND 株式会社カネカ 2020-07-23 — — WO disclosed
EP-2210607-B1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer EXELIXIS INC (US) 2011-08-17 — — EP disclosed
Send feedback